Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium

Publisher： John Wiley & Sons Inc

E-ISSN： 2056-4538|1|1|18-32

ISSN： 2056-4538

Source： The Journal Of Pathology: Clinical Research, Vol.1, Iss.1, 2015-02, pp. : 18-32

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Engineering Tissue Model for Anti-Breast Cancer Pharmacotherapy

By  

Current Tissue Engineering, Vol. 1, Iss. 1, 2012-10 ,pp. : 15-23

Bentham Science Publishers

Access to resources Recommend Favorite

Extended trastuzumab therapy improves the survival of HER2positive breast cancer patients following surgery and radiotherapy for brain metastases

By                            

Molecular and Clinical Oncology, Vol. 1, Iss. 6, 2013-01 ,pp. : 995-1001

Spandidos Publications

Access to resources Recommend Favorite

Antiangiogenic Agents in the Treatment of HER2-Negative Metastatic breast Cancer: A Brief Review

By  

Current Angiogenesis, Vol. 3, Iss. 2, 2014-07 ,pp. : 73-79

Bentham Science Publishers

Access to resources Recommend Favorite

GPER and ER: Estrogen Receptors with Distinct Biological Roles in Breast Cancer

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 11, Iss. 4, 2011-12 ,pp. : 243-254

Bentham Science Publishers

Access to resources Recommend Favorite

Expression of the breast cancer resistance protein and 5fluorouracil resistance in clinical breast cancer tissue specimens

By        

Molecular and Clinical Oncology, Vol. 1, Iss. 5, 2013-01 ,pp. : 853-857

Spandidos Publications

Access to resources Recommend Favorite